Sjögren's Syndrome Insights

Autoimmune Hepatitis and Sjögren's Syndrome Overlap Case

Top Stories

Latest Research

Recent research highlights significant immune changes in patients with primary Sjögren’s disease (pSjD). A study compared immune cell types and interferon expression in placentas from patients with systemic lupus erythematosus and pSjD, revealing higher levels of Myxovirus resistance protein 1 and an increased count of macrophages in the placentas of those with pSjD. These findings suggest that immune dysregulation may play a crucial role in the pathophysiology of Sjögren’s syndrome, indicating potential avenues for targeted therapies and a deeper understanding of the disease's impact on systemic health.

The study emphasizes the importance of recognizing immune alterations in Sjögren’s syndrome, which can lead to various systemic complications. This research contributes to the growing body of evidence that links autoimmune conditions with significant immune system changes, potentially paving the way for improved diagnostic and therapeutic strategies in managing Sjögren’s syndrome and related disorders. (Fierro, 2025)

Clinical Trials

This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome
Study Type
Phase II
Location
17 countries
Age Range
18 - 75 Years
Enrollment
262
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
Study Type
Phase III
Location
34 countries
Age Range
18+ Years
Enrollment
756
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State
Study Type
Phase III
Location
27 countries
Age Range
18+ Years
Enrollment
435
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
Study Type
Phase III
Location
28 countries
Age Range
18+ Years
Enrollment
621

Community News

Sjögren's FoundationSjögren's FoundationApr 01, 2025

Sjögren’s disease is one of the most prevalent yet underrecognized autoimmune diseases, affecting millions of people worldwide. Despite its impact, awareness remains low, and many patients experience delays in diagnosis and a lack of treatment options.

This month, we invite you to Connect, Learn and Thrive. Connect with the Sjögren’s community,

Learn more about the disease and ways to bring awareness to its impact, and Thrive by accessing resources and support that empower you to live your best life with Sjögren’s.

Click the link below to learn more about Sjögren's Awareness Month:

https://www.sjogrens.org/sjogrensmonth

#ThisIsSjögrens

Sjögren's Foundation Post
Sjögren's FoundationSjögren's FoundationApr 03, 2025

Sjögren's is a complex disease and can be difficult to diagnose, and it's not uncommon to face challenges along the way. If you feel like something isn't right, continue to advocate for yourself and be persistent in your search for answers.

Currently, the two most prevalently used tests to clearly diagnose Sjögren’s are testing positive on a lip biopsy and testing positive for a prominent autoantibody associated with Sjögren’s known as anti-SSA (also called anti-Ro). However, an estimated 40% of Sjögren's patients are considered 'Seronegative', meaning they are not positive for anti-SSA, despite having clear indications of having Sjögren's disease.

Beyond Sjögren'sBeyond Sjögren'sApr 01, 2025

April is Sjögren's Awareness Month, and we want to take this opportunity to bring awareness to the challenges that people with Sjögren's suffer with:

👉 What is Sjögren's?

Sjögren's is a relatively common autoimmune disease that is most commonly known for damaging moisture producing glands - like tear and saliva glands - causing severe dry eyes and/or mouth.

However, the disease often impacts far more these glands, and can affect the whole body, causing deilitating fatigue, digestive issues, joint and nerve pain, brain fog and more.

👉 How does it affect those who suffer with it?

- They often live with a deep exhaustion that doesn’t improve with rest and can make even the simplest tasks feel overwhelming.

- Joint pain, nerve pain, and muscle aches are common and may come and go unpredictably.

- Many also experience brain fog, which makes it difficult to concentrate, find the right words, or think clearly.

- The disease can also affect the gut, pancreas, liver, and nutrient absorption, leading to digestive and nutritional challenges.

- Since it’s an invisible illness, this can bring emotional strain, including feelings of isolation, misunderstanding, and the pressure to keep going despite everything.

- Flare-ups often strike without warning, making it difficult to plan ahead or keep up with daily life.

- Most people spend years searching for answers before finally receiving a diagnosis.

- Many also experience dismissal or a lack of support from health professionals, often due to how nonspecific or misunderstood the symptoms can be.

Despite how life-altering it can be, and how relatively common it is, Sjögren’s receives far less funding and public attention compared to other autoimmune conditions.

People with Sjögren’s deserve to be seen, heard and supported. Let’s hope we can move closer to that goal this April.

Share this post to raise awareness!

--

Upcoming Events

APR
11
Sjögren's Disease Patient ConferenceOnline Sjögren's Foundation • Reston, VA